Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy in Evaluation of Hypermetabolic Lymphadenopathy Mediastinum Lower, Rear and Middle, Detected in PET-CT to 18 FDG (PET)

NCT01892501 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT01892501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01892501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study on the Contribution of Guided Puncture With Echoendoscopy in Evaluation of Hypermetabolic Lymphadenopathy Mediastinum Lower, Rear and Middle, Detected in PET-CT to 18 FDG (PET)
Lead sponsor
Institut Bergonié
Phase
Not applicable
Overall status
Completed
Start date
January 8, 2013
Completion date
October 10, 2019
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypermetabolic lymphadenopathy mediastinum lower, posterior and middle, detected by pet-ct with 18f-fdg (pet)